scispace - formally typeset
Search or ask a question

Showing papers on "Benzopyrans published in 1990"


Journal ArticleDOI
TL;DR: The synthesis and antihypertensive activity in the spontaneously hypertensive rat of two new series of analogues related to cromakalim are described, where the benzopyran nucleus has been replaced by a pyranopyridine nucleus.
Abstract: The synthesis and antihypertensive activity in the spontaneously hypertensive rat of two new series of analogues related to cromakalim (1) are described. In the first series, where the benzopyran nucleus has been replaced by a pyranopyridine nucleus, the position of the nitrogen atom has been found to be critical for activity, and the most potent compounds are the pyrano[3,2-c]pyridines. In the second series, where the powerful electron-withdrawing cyano group of compound 1 has been replaced by alkyl and phenyl groups, the order of antihypertensive potency is ethyl, isopropyl, tert-butyl greater than propyl, cyclopentyl greater than methyl greater than phenyl.

54 citations


Journal ArticleDOI
TL;DR: The benzopyran 16 was found to be more effective antiestrogen than tamoxifen while being as effective as LY-117018 and has thus emerged as a new class of potent antiestrogens.
Abstract: A series of 2,3-diaryl-1-benzopyran analogues substituted at position 4 of 2-phenyl with a hydroxy or pyrrolidinoethoxy residue were synthesized as models for (E)-triarylpropenones constrained in the s-trans conformation. The prototypes, belonging to five chemical series, were evaluated for their estrogen receptor affinity and for estrogen agonist-antagonist activities. The 4H-1-benzopyran-4-one, the 2,3-dihydro-4H-1-benzopyran-4-one, the 4H-1-benzopyran, and the 2,3-dihydro-1-benzopyran derivatives were found to be inactive or only marginally activate as receptor ligands or estrogen agonists-antagonists. In the 2H-1-benzopyran category the parent phenol was also inactive whereas the basic ethers 16 and 26 were modest receptor ligands while being quite active as antiestrogens. In a comparative study the benzopyran 16 was found to be more effective antiestrogen than tamoxifen while being as effective as LY-117018. The benzopyrans have thus emerged as a new class of potent antiestrogens.

53 citations


Journal ArticleDOI
TL;DR: Twohenolic analogues of 2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran, a novel antiestrogen, were synthesized and evaluated for their structure-activity relationship and were found to be good receptor ligands and better antiestrogens than tamoxifen, trioxIFen, and LY-117018.
Abstract: Phenolic analogues of 2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran (1), a novel antiestrogen, were synthesized and evaluated for their structure-activity relationship. Incorporation of OH at position 7 was found to improve receptor affinity of the benzopyran while having no effect on its action as an antagonist. Similar substitution of 2-phenyl as well potentiated receptor affinity as well as antagonist activity of the prototype. The monophenol 19 and the diphenol 25 were thus found to be good receptor ligands, devoid of estrogen agonist activity and associated with marked antiestrogenic activity of comparable order. Both caused nearly complete inhibition of the estradiol stimulated uterine growth in rats as well as mice and were thus found to be better antiestrogens than tamoxifen, trioxifen, and LY-117018. A binding-site model for estrogen receptor rationalizing the structure-activity relationship of benzopyrans in relation to that of the triarylethylene and the triarylpropenone antiestrogens has been discussed.

47 citations


Journal ArticleDOI
TL;DR: In this article, the novel title compounds 5 were prepared by a simple and efficient two-step procedure starting from substituted benzaldehydes, and a convenient route to the (2-chloro-2-nitroethenyl)benzenes required as intermediates in the synthesis was reported.
Abstract: The novel title compounds 5 are prepared by a simple and efficient two-step procedure starting from substituted benzaldehydes 1. A convenient route to the (2-chloro-2-nitroethenyl)benzenes 3 required as intermediates in the synthesis is reported.

26 citations


Patent
09 Aug 1990
TL;DR: In this paper, the authors provided compounds of formula I for breast cancer, where R 1 and R 2, which may be the same or different, are each -H, -OH, alkoxy of 1 to 17 carbon atoms or alkoxy carbonyl of 2 to 18 carbon atoms and R 3 is useful in the treatment of an estrogen dependent condition.
Abstract: The present invention provides compounds of formula I wherein R 1 and R 2 , which may be the same or different, are each -H, -OH, alkoxy of 1 to 17 carbon atoms or alkoxycarbonyl of 2 to 18 carbon atoms and R 3 is are useful in the treatment of an estrogen dependent condition such as breast cancer.

23 citations



Journal ArticleDOI
TL;DR: In this paper, a β-addition of salicylic aldehyde to 1-nitroglycals, followed by a Henry reaction, is described, which gives the cis-annelated pyranobenzopyranes 9 and 11 from 5 in 54 and 9% yield.
Abstract: Synthesis of Pyranol [3,2-b][1]benzopyrans from 1-Nitroglycals A synthesis of pyrano[3,2-b][l]benzopyrans β-addition of salicylic aldehyde to 1-nitroglycals, followed by a Henry reaction, is described. This sequence gave the cis-annelated pyranobenzopyranes 9 and 11 from 5 in 54 and 9% yield, respectively, demonstrating the pronounced diastereoselectivity of the β-addition. Reductive denitration of the crude product mixture yielded 14(75%), 15(15%), and 16(7%), which were oxidized to the aryl ketones 20 and 21, respectively. Reduction of 20 (NaBH4) gave exclusively 15. The ketone 20 was deprotected to 22 and 23.

8 citations



Patent
20 Jul 1990
TL;DR: In this paper, the present invention is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein Y, R 2, R 3, R 4, R 5, R 6, R 7, a and b are as defined in the Specification, having pharmacological activity, to a process for their preparation, and to their use as pharmaceuticals.
Abstract: The present invention is directed to compounds of formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein Y, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , a and b are as defined in the Specification, having pharmacological activity, to a process for their preparation, and to their use as pharmaceuticals.

2 citations


Patent
11 Apr 1990
TL;DR: In this article, novel benzopyrans having pharmacological activity, a process for preparing them, pharmaceutical compositions containing them, and their use in the treatment of hypertension are presented.
Abstract: Disclosed herein are novel benzopyrans having pharmacological activity, a process for preparing them, pharmaceutical compositions containing them, and their use in the treatment of hypertension.

2 citations


Journal ArticleDOI
TL;DR: In this paper, the novel title compounds 5 were prepared by a simple and efficient two-step procedure starting from substituted benzaldehydes, and a convenient route to the (2-chloro-2-nitroethenyl)benzenes required as intermediates in the synthesis was reported.
Abstract: The novel title compounds 5 are prepared by a simple and efficient two-step procedure starting from substituted benzaldehydes 1. A convenient route to the (2-chloro-2-nitroethenyl)benzenes 3 required as intermediates in the synthesis is reported.


Patent
26 Nov 1990
TL;DR: A process for the preparation of a compound of formula (A)' or (A)'': which process comprises the base treatment of a quaternary ammonium salt of a compounds of formula(D): wherein the NH₂ and OH moieties are trans and are (R,S) or (S,R) respectively as discussed by the authors.
Abstract: A process for the preparation of a compound of formula (A)' or (A)'': which process comprises the base treatment of a quaternary ammonium salt of a compound of formula (D): wherein the NH₂ and OH moieties are trans and are (R,S) or (S,R), respectively.

Journal ArticleDOI
TL;DR: Trans -3-hydroxy-4-(2-oxopyrrolidin-1-yl) benzopyrans have been shown to undergo inversion to cis -3hydrox 4-(2.oxoplyridin) 1-yl (1.1)-benzopyrrole in moderate yield on treatment with diethylaminosulphur trifluoride (DAST) as mentioned in this paper.
Abstract: Trans -3-hydroxy-4-(2-oxopyrrolidin-1-yl) benzopyrans have been shown to undergo inversion to cis -3-hydroxy-4-(2-oxopyrrolidin-1-yl) benzopyrans in moderate yield on treatment with diethylaminosulphur trifluoride (DAST).

Journal ArticleDOI
TL;DR: Les substitutions nucleophiles des chromannes du titre avec le [cyano trimethyl] silane sont etudiees as mentioned in this paper, and le catalyseur, TiCl 4 ou SnCl 4, a une influence sur la regioselectivite des reactions
Abstract: Les substitutions nucleophiles des chromannes du titre avec le [cyano trimethyl] silane sont etudiees. Le catalyseur, TiCl 4 ou SnCl 4 , a une influence sur la regioselectivite des reactions

Journal ArticleDOI
TL;DR: Mannich bases of types 1 or 8, which are readily synthesized by condensation of 3,4-methylenedioxyphenol with aromatic aldehydes and pyrrolidine or piperazine, react with cyclic and acyclic β-diketones to yield benzopyrans.
Abstract: Mannich bases of types 1 or 8, which are readily synthesized by condensation of 3,4-methylenedioxyphenol with aromatic aldehydes and pyrrolidine or piperazine, react with cyclic and acyclic β-diketones to yield benzopyrans. These benzopyrans are structurally similar to podophyllotoxin and like this drug some of the benzopyrans show in vivo anti-leukemic action in mice.

Patent
11 Sep 1990
TL;DR: In this article, novel benzopyrans having pharmacological activity, to a process for preparing them, to pharmaceutical compositions containing them, and to their use in the treatment of hypertension are presented.
Abstract: Disclosed herein are novel benzopyrans having pharmacological activity, to a process for preparing them, to pharmaceutical compositions containing them, and to their use in the treatment of hypertension.

Patent
07 Feb 1990
TL;DR: In this article, novel benzopyrans having pharmacological activity, to a process for preparing them, to pharmaceutical compositions containing them, and to their use in the treatment of hypertension are presented.
Abstract: Disclosed herein are novel benzopyrans having pharmacological activity, to a process for preparing them, to pharmaceutical compositions containing them, and to their use in the treatment of hypertension.

Patent
30 Oct 1990
TL;DR: In this paper, the meanings of the benzopyrans of the formula "STR1" and "STR2" are described, a process for their preparation, and their use in pressure-sensitive or heat-sensitive layers.
Abstract: Benzopyrans of the formula ##STR1## where X is a radical ##STR2## and R1, R2, R3, R4 and the ring A have the meanings stated in the description, a process for their preparation, and their use in pressure-sensitive or heat-sensitive layers.